CELU – celularity inc. - class a (US:NASDAQ)

News

5 Startup Opportunities In Anti-Ageing [Forbes]
Exosome Therapeutics Pipeline research 2024 [Yahoo! Finance]
Celularity Presents Data of The Effect of Its T-Cell Platform on Multiple Hematological And Solid Tumors at the American Society of Clinical Oncology (ASCO) Annual Meeting [Yahoo! Finance]
Celularity Presents Data of The Effect of Its T-Cell Platform on Multiple Hematological And Solid Tumors at the American Society of Clinical Oncology (ASCO) Annual Meeting
Celularity announces receipt of Nasdaq notice regarding late Form 10-Q filing [Seeking Alpha]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com